Injectable Influenza Vaccine
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2DP24R0003
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
-
- Kevin Weintraub kevin.weintraub@dla.mil (215) 737-8600
- Theresa Rucci theresa.rucci@dla.mil (856) 491-0580
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support is soliciting for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The vaccines must be FDA-approved and ACIP recommended, and shall be provided in multi-dose vials and prefilled syringes for various age categories. An indefinite quantity contract is proposed, with a guaranteed minimum of 75% of the annual estimate and a contract maximum of 150%. The contractor must be capable of delivering 40% of the requirement by August 11, 2025, 25% by August 25, 2025, 25% by September 8, 2025, and the residual 10% by September 22, 2025.
This opportunity is not set-aside, and the NAICS code is 325414 - Biological Product (except Diagnostic) Manufacturing. The PSC code is 6505 - Drugs And Biologicals. No information is provided about potential incumbents or current contractors, and the budget or award value range is not specified.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2025-2026 flu season. Approximately 3.35 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in the following presentations: multi-dose vials and prefilled syringes. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and a 10-pack prefilled syringes for immunizing 6 months to 35 months (pediatric group).
The formula for the 2025-2026 season shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 11, 2025, 25% by August 25, 2025, 25% by September 8, 2025, and the residual 10% by September 22, 2025. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Influenza Vaccine | Award Notice | |
| Injectable Influenza Vaccine | Solicitation | |
| Injectable Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity